Home > Category > Signaling Pathways > Cytoskeletal Signaling

Cytoskeletal Signaling

41 related results
Display mode
All
All
ProductNum picture CAS No. Name and description Formula Quick order
CL1844A
253128-41-5

Eribulin | B1939 | E7389 | ER-086526

98+%

C40H59NO11
CL1869
908112-43-6

SNX 2112 | PF-04928473

98+%

C23H27F3N4O3
CL2903B
142373-60-2

Tirofiban hydrochloride | L700462 hydrochloride | MK383 hydrochloride)

98+%

C22H37ClN2O5S
CL2903A
144494-65-5

Tirofiban | L700462 | MK383

98+%

C22H36N2O5S
CL2903
150915-40-5

Tirofiban Hydrochloride monohydrate | Tirofiban HCl | L700462 hydrochloride monohydrate | MK383 hydrochloride monohydrate

98+%

C22H39ClN2O6S
CL2890
1228445-38-2

Pyrintegrin | PTN

98+%

C23H25N5O3S
CL2726
796073-69-3

DM4

95+%

C38H54ClN3O10S
CL2644
1642288-47-8

Mavacamten (MYK-461)

98+%

C15H19N3O2
CL1348A
1415246-68-2

MMAF Hydrochloride;Monomethylauristatin F Hydrochloride

98+%

C39H66ClN5O8
CL2467
1025967-78-5

Lifitegrast; SAR 1118

98+%

C29H24Cl2N2O7S
CLA1358
1342290-43-0

Abrilumab (Anti-Integrin a4b7 ITGA4 & ITGB7)

95+%

CLA1352
1105038-73-0

Abituzumab (Anti-Integrin aV / ITGAV / CD51)

95+%

CLA1265
1044758-60-2

Etrolizumab (Anti-Integrin α4β7) (ITGA4 & ITGB7)

95+%

CLA1226
339086-79-2

Rovelizumab

95+%

CLA1211
211323-03-4

Erlizumab (Anti-Integrin b2 / ITGB2 / CD18)

95+%

CLA1196
558480-40-3

Volociximab (Anti-Integrin a5b1 (ITGA5 & ITGB1))

95+%

CLA1185
892553-42-3

Etaracizumab

95+%

CLA1118
143653-53-6

Abciximab

95+%

CLA1108
159445-64-4

Odulimomab

95+%

CLA1097
142864-19-5

Enlimomab

95+%

1 2 3
Service
ChemLeader
021-58180488
Online service time: 9:00-18:00 on weekdays